Literature DB >> 9667650

Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer.

A B Alexandroff1, C A McIntyre, J C Porter, J Zeuthen, R G Vile, D D Taub.   

Abstract

The Second Meeting of the British Society for Immunology Tumour Immunology Affinity Group (TIAG) took place at King's College (London, UK) on 17-18 June 1997 and brought together over 100 tumour immunologists from the UK and abroad. In contrast to previous meetings the focus of the meeting was on the role of adhesion in immunosurveillance and tumour dissemination. In addition, recent achievements in the areas of chemokines, cytotoxic T-lymphocyte (CTL) and natural killer (NK) cells, co-stimulation, gene and adoptive immunotherapy were also addressed. The purpose of this report is to outline current trends in tumour immunology.

Entities:  

Mesh：

Year:  1998        PMID： 9667650      PMCID： PMC2150337          DOI： 10.1038/bjc.1998.300

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  29 in total

1.  Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154.

Authors:  M F Mackey; J R Gunn; P P Ting; H Kikutani; G Dranoff; R J Noelle; R J Barth
Journal:  Cancer Res       Date:  1997-07-01       Impact factor: 12.701

Review 2.  Chemokine-leukocyte interactions. The voodoo that they do so well.

Authors:  D D Taub
Journal:  Cytokine Growth Factor Rev       Date:  1996-12       Impact factor: 7.638

Review 3.  Chemokines, inflammation and the immune system.

Authors:  D D Taub; J J Oppenheim
Journal:  Ther Immunol       Date:  1994-08

Review 4.  Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production.

Authors:  D D Taub; J R Ortaldo; S M Turcovski-Corrales; M L Key; D L Longo; W J Murphy
Journal:  J Leukoc Biol       Date:  1996-01       Impact factor: 4.962

5.  Neonatal tolerance revisited: turning on newborn T cells with dendritic cells.

Authors:  J P Ridge; E J Fuchs; P Matzinger
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

6.  Cancer biologists hit the road. Molecular genetics of cancer: Second Joint Conference of the American Association for Cancer Research and the European Association for Cancer Research. Oxford, UK, 9-13 September 1997. Cancer gene therapy symposium. London, UK, 23-24 June 1997.

Authors:  A B Alexandroff; A G Dalgleish
Journal:  Mol Med Today       Date:  1997-12

7.  Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions.

Authors:  R Giavazzi; M Foppolo; R Dossi; A Remuzzi
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.

Authors:  M Azuma; M Cayabyab; D Buck; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

9.  Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells.

Authors:  N Matsuura; W Puzon-McLaughlin; A Irie; Y Morikawa; K Kakudo; Y Takada
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

10.  Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.

Authors:  J Schøller; P thor Straten; A Birck; E Siim; K Dahlström; K T Drzewiecki; J Zeuthen
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968
View more
  1 in total

1.  Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat.

Authors:  Monica R Hazelrigg; Jerry I Hirsch; Randall E Merchant
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.